226 related articles for article (PubMed ID: 26676415)
1. Modulation of the Innate Immune Response by Human Neural Precursors Prevails over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model of Pelizaeus-Merzbacher Disease.
Marteyn A; Sarrazin N; Yan J; Bachelin C; Deboux C; Santin MD; Gressens P; Zujovic V; Baron-Van Evercooren A
Stem Cells; 2016 Apr; 34(4):984-96. PubMed ID: 26676415
[TBL] [Abstract][Full Text] [Related]
2. Is involvement of inflammation underestimated in Pelizaeus-Merzbacher disease?
Marteyn A; Baron-Van Evercooren A
J Neurosci Res; 2016 Dec; 94(12):1572-1578. PubMed ID: 27661457
[TBL] [Abstract][Full Text] [Related]
3. Neurogenetics of Pelizaeus-Merzbacher disease.
Osório MJ; Goldman SA
Handb Clin Neurol; 2018; 148():701-722. PubMed ID: 29478609
[TBL] [Abstract][Full Text] [Related]
4. Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.
Osorio MJ; Rowitch DH; Tesar P; Wernig M; Windrem MS; Goldman SA
Stem Cells; 2017 Feb; 35(2):311-315. PubMed ID: 27882623
[TBL] [Abstract][Full Text] [Related]
5. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
Elitt MS; Tesar PJ
Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
[TBL] [Abstract][Full Text] [Related]
6. Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain.
Tatar CL; Appikatla S; Bessert DA; Paintlia AS; Singh I; Skoff RP
ASN Neuro; 2010 Sep; 2(4):e00043. PubMed ID: 20885931
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease.
Gruenenfelder FI; McLaughlin M; Griffiths IR; Garbern J; Thomson G; Kuzman P; Barrie JA; McCulloch ML; Penderis J; Stassart R; Nave KA; Edgar JM
Brain; 2020 May; 143(5):1383-1399. PubMed ID: 32419025
[TBL] [Abstract][Full Text] [Related]
8. Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.
Elitt MS; Shick HE; Madhavan M; Allan KC; Clayton BLL; Weng C; Miller TE; Factor DC; Barbar L; Nawash BS; Nevin ZS; Lager AM; Li Y; Jin F; Adams DJ; Tesar PJ
Stem Cell Reports; 2018 Sep; 11(3):711-726. PubMed ID: 30146490
[TBL] [Abstract][Full Text] [Related]
9. Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA.
Li H; Okada H; Suzuki S; Sakai K; Izumi H; Matsushima Y; Ichinohe N; Goto YI; Okada T; Inoue K
JCI Insight; 2019 May; 4(10):. PubMed ID: 31092737
[TBL] [Abstract][Full Text] [Related]
10. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
[TBL] [Abstract][Full Text] [Related]
11. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
[TBL] [Abstract][Full Text] [Related]
12. Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.
Miyamoto Y; Torii T; Tanoue A; Yamauchi J
Biochem Biophys Res Commun; 2012 Jul; 424(2):262-8. PubMed ID: 22750001
[TBL] [Abstract][Full Text] [Related]
13. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
[TBL] [Abstract][Full Text] [Related]
14. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
[TBL] [Abstract][Full Text] [Related]
15. Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease.
Stumpf SK; Berghoff SA; Trevisiol A; Spieth L; Düking T; Schneider LV; Schlaphoff L; Dreha-Kulaczewski S; Bley A; Burfeind D; Kusch K; Mitkovski M; Ruhwedel T; Guder P; Röhse H; Denecke J; Gärtner J; Möbius W; Nave KA; Saher G
Acta Neuropathol; 2019 Jul; 138(1):147-161. PubMed ID: 30919030
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation.
Nobuta H; Yang N; Ng YH; Marro SG; Sabeur K; Chavali M; Stockley JH; Killilea DW; Walter PB; Zhao C; Huie P; Goldman SA; Kriegstein AR; Franklin RJM; Rowitch DH; Wernig M
Cell Stem Cell; 2019 Oct; 25(4):531-541.e6. PubMed ID: 31585094
[TBL] [Abstract][Full Text] [Related]
17. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
[TBL] [Abstract][Full Text] [Related]
18. Pelizaeus-Merzbacher disease: cellular pathogenesis and pharmacologic therapy.
Torii T; Miyamoto Y; Yamauchi J; Tanoue A
Pediatr Int; 2014 Oct; 56(5):659-66. PubMed ID: 25040584
[TBL] [Abstract][Full Text] [Related]
19. Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication.
Clark K; Sakowski L; Sperle K; Banser L; Landel CP; Bessert DA; Skoff RP; Hobson GM
J Neurosci; 2013 Jul; 33(29):11788-99. PubMed ID: 23864668
[TBL] [Abstract][Full Text] [Related]
20. Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet.
Saher G; Rudolphi F; Corthals K; Ruhwedel T; Schmidt KF; Löwel S; Dibaj P; Barrette B; Möbius W; Nave KA
Nat Med; 2012 Jul; 18(7):1130-5. PubMed ID: 22706386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
